multiplex assays
The firm expects to establish a US-based development and manufacturing footprint for its multiplex PCR assay kits.
Genetic Analysis Receives CE Mark for Microbiome Test on Luminex Magpix Instrument
Receipt of the CE mark will provide the Norwegian firm access to the large number of labs that already have the platform, expanding its addressable market, it said.
FIND Invests $21M to Launch POC MDx Platforms for Infectious Disease
Four companies have been selected for investment: Biomeme, Bioneer, Qlife, and SD Biosensor.
Cepheid Gets $28M From BARDA for SARS-CoV-2 Tests
The funding is for the firm's SARS-CoV-2, pan-coronavirus, and multiplex SARS-CoV-2, influenza, and respiratory syncytial virus tests, according to BARDA.
Israeli Diagnostics Firm NanoSynex Aiming for European Market Entry for AMR Test by 2023
The European Commission recently awarded the company a two-year, €2.6 million Horizon 2020 grant to achieve its ambitions.
Oct 22, 2020
Danaher Q3 Revenues Up 35 Percent
Mar 4, 2020
Randox Laboratories STI Assay Gets CE Mark
May 9, 2019
NanoString Revenues Climb 18 Percent in Q1
Jan 16, 2019
First Light Diagnostics Raises $8.25M
Jul 16, 2018
Biomarker-Based Dx Firm Kypha Buys Biosensia
Jun 29, 2018
Apr 19, 2018
Mobidiag Gets CE Marks for Two Tests
Feb 14, 2018